The QualityStocks Daily Friday, October 11th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (SMTA) +1,624.00%

PennyPickAlerts (BMMCF) +333.21%

SmallCapRelations (NTRR) +153.33%

The QualityStocks Daily Stock List

Gungnir Resources, Inc. (ASWRF)

Mining Capital, Gold Stock Data, Proactive Investors, Wallmine, Junior Mining Network, Stock Scores, Canadian Insider, Wallet Investor, Stockhouse, InvestorsHub, Dividend Investor, Investors Hangout, TradingView, and Northern Miner reported previously on Gungnir Resources, Inc. (ASWRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Gungnir Resources, Inc. is a mineral exploration company focuses on discovery in mineral-rich Sweden. It holds gold and base metal exploration permits in Sweden’s prolific Vasterbotten District, which hosts 12 million ounces of gold delineated in existing and mined resources plus several past-producing and producing volcanogenic massive sulphide (VMS) base metal mines. Gungnir Resources is headquartered in Surrey, British Columbia.

The Company’s principal focus is the Knaften project situated at the south end of the “Gold Line” (Knaften-Barsele Arc) that hosts a number of gold deposits. These include Faboliden and Svartliden (Dragon Mining), and also the Barsele Gold-VMS project (Agnico Eagle). In 2017 and 2018, successful drill programs at Knaften resulted in back-to-back new base metal target discoveries; the Rodingtrask VMS and a Cu-Ni target positioned only 400 meters to the east. All three targets on Knaften are wide-open for expansion and further discovery.

Gungnir Resources also holds an advance royalty from the sale of a gold project in British Columbia in 2014. The Company has received $3M so far from the project sale. $3M is still due to Gungnir in annual $1M payments. In addition, Gungnir holds permits covering two nickel deposits, Lappvattnet and Rormyrberget, which collectively host 70 million pounds of nickel in historical resources, and the earlier staked Norrbotten gold and base metal permits in the Norrbotten District of Sweden.

In late September, Gungnir Resources announced that its summer diamond drilling program at its Knaften project was completed. A total of 1,900 m was drilled in ten holes - five holes testing the Rodingtrask volcanogenic massive sulphide (VMS) target, and five holes testing the Knaften 300 Gold Zone.

Last week, Gungnir Resources announced a new, high-grade gold discovery at Knaften. Assay results include 59.6 g/t Au (1.92 opt Au) over 1.0 m (3.28 ft) within the newly discovered Lower Zone at the Knaften 300 Gold Zone (Knaften 300).

Jari Paakki, Gungnir Resources’ Chief Executive Officer, said, "With discovery of high-grade gold and the predictability of the Knaften 300 mineralized zones, we have now moved this target to the top of our list. We believe we have a great chance for further discoveries down-dip and to potentially find additional stacked zones at depth. We eagerly await further assays from our 2019 drill program."

Gungnir Resources, Inc. (ASWRF), closed Friday's trading session at $0.0667, even for the day, on 15,000 volume. The average volume for the last 3 months is 21,661 and the stock's 52-week low/high is $0.037399999/$0.110100001.

chart

Magellan Gold Corporation (MAGE)

Mining Capital, Market Screener, Street Insider, Equities, Investors Hangout, The OTC Reporter, Mining Stock Valuator, Mining Clips, Stockwatch, InvestorsHub, Stockhouse, Proactive Investors, YCharts, and Wallet Investor reported beforehand on Magellan Gold Corporation (MAGE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Magellan Gold Corporation intends to establish itself as a major player in the precious metals mining field. It is an exploration stage company and its principal business is the acquisition, exploration, and if warranted, development of mineral resources. Magellan controls three projects comprising the SDA Mill, Mexico; the El Dorado Gold-Silver Project near the SDA Mill; and the Silver District Property, Arizona. Magellan Gold is based in Albuquerque, New Mexico and the Company lists on the OTC Markets’ OTCQB.

Magellan Gold’s intention is to build up production through the SDA Mill and increase cash flow. Initial production from the El Dorado Gold-Silver Project was planned for this year, with the ore to be trucked to the SDA Mill for treatment. Other precious metals properties within trucking distance of the SDA Mill have been identified for acquisition. Furthermore, the Company will leverage opportunities to treat ore on a toll basis for third-party suppliers.

The SDA Processing Plant is a permitted, fully operational flotation mill with gold-silver leach circuit located in Nayarit State, Mexico. The SDA Processing Plant (SDA Mill) is 150 kilometers southeast of the City of Mazatlan near the town of Acaponeta, Nayarit. Magellan Gold purchased the SDA Mill and associated assets, licenses, and agreements in November of 2017 for $1.5 million.

The Silver District Project is an advanced-stage exploration project in southwest Arizona. The Silver District Project in La Paz County holds promising potential for expansion of an historic 16 million ounce silver resource, and development of a silver mine with by-products fluorspar, barite and lead-zinc. The property comprises more than 2,000 acres of patented and unpatented mining claims and an Arizona state exploration permit. It covers all of the important historic mines and prospects in the Silver District.

The El Dorado Gold-Silver Project is planned to be developed as an underground mine to supply feed to the SDA Mill. The El Dorado Gold-Silver Project is near the village of Las Minitas, State of Nayarit, 50 kilometers south of the SDA Processing Plant. The El Dorado Mining Concession comprises a 50-hectare concession valid until March 2030. Magellan Gold holds the concession under an option to purchase.

Last week, Magellan Gold announced agreements effective September 30, 2019, with its primary secured creditors and largest shareholder to convert an aggregate of $2.45 million of outstanding debt obligations (including a secured line of credit, outstanding promissory notes and advances) into a newly-created series of Preferred Shares of the Company. The Preferred Shares will carry a $2.45 million liquidation preference, subject to adjustments, be convertible into common stock at $1.00 per share and bear a 10 percent annual dividend payable in kind at the option of Magellan Gold. The Agreements release and reduce liens on certain assets of the Company and convert portions of its secured and unsecured debt holdings to Preferred Shares to enhance the balance sheet and facilitate new financing arrangements.

Magellan Gold Corporation (MAGE), closed Friday's trading session at $1.63, even for the day, on 2 volume. The average volume for the last 3 months is 658 and the stock's 52-week low/high is $0.800000011/$3.79999995.

chart

MariMed, Inc. (MRMD)

Daily Marijuana Observer, CannabisNewsWire, Stock of the Week, Trading View, CannabisMarketCap, Super Stock Screener, Micro Small Cap, NIC Investors, Equity Clock, Stockhouse, PotStockNews, Morningstar, and Profit Confidential reported earlier on MariMed, Inc. (MRMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MariMed, Inc. is a foremost multi-state cannabis operator centered on health and wellness. The Company’s commitment is to improving health and wellness with the highest quality hemp and cannabis products. It offers a complete range of cannabis products and operates state-of-the-art cannabis dispensaries in six States. In addition, MariMed has a separate division, MariMed Hemp, centered on the development of industrial hemp-derived CBD (cannabidiol) products. MariMed has its corporate office in Norwood, Massachusetts. The Company lists on the OTCQX.

MariMed is a first mover into the hemp CBD market. It has supply and products in the U.S. and the European Union (EU). Its emphasis is the continuing discovery of better wellness through cannabis and hemp. The Company’s platform consists of a vertically integrated approach.

Regarding Seed-to-Sale, MariMed has extensive experience with the broad array of issues relevant to legal cannabis business activities. This includes licensing for cultivation, processing and dispensing, litigation, banking and finance, raising and deploying capital, protecting intellectual property (IP), real estate development and leasing, and additional clickthroughs.

Concerning its brands and products, MariMed starts with a quality growing medium, rich genetics, and natural nutrients to formulate products for varying speeds and methods of delivery. Its products always include a broad variety of dosing preferences and rich terpene profiles.

MariMed holds 13 cannabis licenses for cultivation, production, and dispensaries across 6 U.S. States. At present, the Company is managing greater than 300,000 square feet of premier cannabis facilities. In addition, MariMed supports research and physician education, supported by the Scientific Advisory Board.

MariMed holds a 33.5 percent stake in GenCanna Global. GenCanna is a Kentucky-based national leader in seed-to-sale of GMP-quality, hemp-derived CBD. Furthermore, in Q2, MariMed acquired a minority interest in Terrace, Inc. Terrace is a Canadian-based operator. Terrace concentrates on the acquisition and development of worldwide cannabis assets in Europe and South America.

In September, MariMed announced that the HempEngine™ group of its MariMed Hemp subsidiary signed an exclusive agreement with one of the largest beverage distributors located in the Northeast U.S., serving over 8,500 on- and off-premise locations. With this agreement, the HempEngine platform will be placed in locations in Rhode Island and Connecticut that include retailers, liquor stores, and supermarkets.

The locations will receive the HempEngine turnkey CBD marketing platform, a complete “store-within-a-store” package, pre-stocked with a range of CBD products focused on a location owner’s particular criteria. In addition to curated brands, HempEngine includes the tech-enabled re-marketing platform, Sprout™.

This week, MariMed announced it appointed Mr. Phil Frankenberg as President of its MariMed Hemp subsidiary. Mr. Frankenberg brings to MariMed Hemp greater than 25 years of retail and wholesale experience in brand development, corporate strategy, and operations. He will focus on raising awareness and boosting sales of MariMed Hemp’s top-quality hemp-derived CBD brands, including Florance™ and Healer.

MariMed, Inc. (MRMD), closed Friday's trading session at $0.77, even for the day, on 178,633 volume with 159 trades. The average volume for the last 3 months is 374,876 and the stock's 52-week low/high is $0.671000003/$5.36999988.

chart

Mobivity Holdings Corp. (MFON)

NetworkNewsWire, Zacks, TipRanks, OTC Markets, Stockopedia, Stockhouse, Dividend Investor, TMXmoney, Insider Tracking, GlobeNewswire, Stockwatch, Last10k, Market Screener, YCharts, Street Insider, Investors Hangout, Wallet Investor, Infront Analytics, MacroTrends, Nasdaq, TradingView, Morningstar, and Simply Wall St reported beforehand on Mobivity Holdings Corp. (MFON), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Mobivity Holdings Corp. is the creator of the award-winning customer personalization platform, Recurrency. The Company provides a platform to connect national restaurants, retailers, personal care brands, and their partners, with customers to increase retention, visits, and also spend. Mobivity Holdings is based in Chandler, Arizona and has an office in Halifax, Nova Scotia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Mobivity Holdings’ Recurrency suite of products increases customer engagement and frequency through capturing detailed point-of-sale (POS) transaction records, analyzing customer habits, and motivating customers and employees through data-driven messaging applications and rewards. A business can store transactional POS data in a single location, regardless of what type of POS system its brand uses.

The Company’s patented technology is compatible with most POS systems. It installs easily to provide a simple and cost-effective data solution. The transactional data gathered by way of Recapture allows a business to use Recognition to gain unique insights and create more effective and flexible marketing campaigns, which drive customer frequency, through messages sent via Reach and printed via Receipt.

Recently, Mobivity Holdings announced that Checkers & Rally’s, an iconic and innovative drive-thru restaurant chain, chose Mobivity to power its mobile customer engagement programs in more than 875 of its U.S. locations. The programs will utilize Mobivity’s Reach to send timely, personalized mobile offers to Checkers & Rally’s customers through SMS text messaging. Checkers & Rally’s selected Mobivity due to its patented technologies, which effectively engage customers through personalized mobile campaigns that have been proven to boost customer frequency and spend.

Last week, Mobivity Holdings announced that Mr. Dennis Becker, Mobivity Chairman and Chief Executive Officer (CEO), will moderate the CEO Roundtable focusing on the state of the industry during the Fast Casual Executive Summit on Tuesday, October 15, 2019, at 3:45 p.m. at the JW Marriot in Austin, Texas. The CEO Roundtable (designed specifically for restaurant professionals) brings together leaders in the restaurant industry with interactive discussion, delivering expert insights and takeaways.

Mobivity Holdings Corp. (MFON), closed Friday's trading session at $0.98, even for the day, on 400 volume with 2 trades. The average volume for the last 3 months is 4,735 and the stock's 52-week low/high is $0.709999978/$1.89999997.

chart

PureTech Health plc (PTCHF)

Stock Gumshoe, All Stocks Today, Macroaxis, Real Investment Advice, Finance Recorder, Whale Wisdom, Stockhouse, Investors Hangout, TradingView, Market Screener, Dividend Investor, GuruFocus, Wallet Investor, Nasdaq, TMXmoney, and Morningstar reported earlier on PureTech Health plc (PTCHF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

PureTech Health plc is developing medicines for devastating diseases including intractable cancers, lymphatic, GI diseases, CNS disorders, inflammatory and immunological diseases. A clinical stage biotechnology company, its commitment is to discovering, developing, and commercializing highly differentiated medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis. Incorporated in 2015, PureTech Health has its corporate office in Boston, Massachusetts.

PureTech has created a wide-ranging and deep pipeline via the expertise of its experienced research and development team and its broad network of scientists, clinicians and industry leaders. This pipeline is being advanced internally and through the Company’s affiliates. It consists of 24 product candidates and one product that has been cleared by the US Food and Drug Administration (FDA).

All of the underlying programmes and platforms that resulted in the pipeline of product candidates were initially identified or discovered and subsequently advanced by the PureTech team via key validation points based on the Company’s innovative insights into the biology of the brain, immune, and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis. PureTech Health’s internal programs are centered on harnessing the lymphatic system and related immunology mechanisms for the treatment of cancer, immunological, lymphatic and CNS-related disorders.

This month, PureTech Health announced its acquisition of the remaining minority interests totalling 10 per cent in Ariya Therapeutics, Inc., which has been renamed PureTech LYT, Inc. PureTech LYT is the Company’s now wholly-owned subsidiary, which holds its four technology platforms in immuno-oncology, synthetic lymphatic targeting chemistry, milk exosomes, and meningeal lymphatics. The acquired minority interests were earlier held by the co-inventors of the four platforms and associated universities and advisors.

Daphne Zohar, Founder and Chief Executive Officer of PureTech Health, said, “As we advance our internal pipeline, we believe it is important that the co-inventors of our core technology platforms have an aligned interest in the long-term growth of PureTech. We are pleased with the rapid progress across our internal pipeline since it was first announced just over a year ago. It has also attracted two pharma partnerships, which provide non-dilutive funding that allows us to advance the platforms while retaining the freedom to independently develop the underlying technologies for a broad range of applications.”

PureTech Health plc (PTCHF), closed Friday's trading session at $3.50, up 20.6897%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 5,508 and the stock's 52-week low/high is $2.00999999/$4.00.

chart

The Flowr Corporation (FLWPF)

MicroSmallCap, Growstox, Trading View, CannabisMarketCap, New Cannabis Ventures, CannabisNewsWire, StockAP, Street Insider, NIC Investors, Proactive Investors, Wallet Investor, Equities, GlobeNewswire, Profit Confidential, and Cannabis Daily reported previously on The Flowr Corporation (FLWPF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Flowr Corporation, through its subsidiaries, holds a cannabis production and sales license granted by Health Canada. The Company expects to provide premium-quality cannabis to the adult-use recreational market and the medicinal market. It builds and operates large-scale, GMP-designed cultivation facilities using its own growing systems. The Company has operations in Canada, Europe, and Australia. The Flowr Corporation is based in Toronto, Ontario. The Company also has a production facility in Kelowna, British Columbia.

Flowr cultivates in advanced, state-of-the-art facilities, with its cannabis tended to by its team of experts. Its adult use products include Delahaze, Pink Kush, and Sensi Star. The Company’s medicinal products include BC Ice Cream, BC Delahaze, BC Durga Mata 2 CBD, BC Intergalactic Princess CBD, BC Lemon Thai Kush, BC Pink Kush, BC Sensi Star, and BC OG Sour Diesel.

The Flowr Corporation intends to service the worldwide medical cannabis market via its subsidiary Holigen. This subsidiary has a license for cannabis cultivation in Portugal. Holigen will operate GMP-designed manufacturing facilities in Portugal and Australia.

The Flowr Corporation announced this past June the development of a Clean Stock Protocol. This is a propriety process to certify that its clones are free of pests and pathogens. The use of the Clean Stock Protocol is in addition to industry standard Certificates of Authenticity that attest to THC (tetrahydrocannabinol) and CBD (cannabidiol) content. The Clean Stock Protocol was developed in partnership with Hawthorne Canada Limited, a subsidiary of The Scotts Miracle-Gro Company.

In September, The Flowr Corporation announced that Mr. Ivan Latysh joined the Company as Chief Technology Officer. In this newly created position, Mr. Latysh will be responsible for developing and overseeing the execution of Flowr’s technology and data-driven strategies. Mr. Latysh was most recently, and since 2015, Vice President, Information Technology at MedReleaf Corporation, a cannabis producer focused on the medical market.

Flowr also appointed Messrs. Laurence Levi and Francesco Tallarico to the roles of Chief Strategy Officer and Chief Legal Officer, respectively. Mr. Levi joined the Company in January, 2019, as Executive Vice President, Head of Strategy. Mr. Tallarico joined the Company effective October 1, 2018, as General Counsel and Corporate Secretary.

The Flowr Corporation (FLWPF), closed Friday's trading session at $1.56383, up 14.1482%, on 199,009 volume with 381 trades. The average volume for the last 3 months is 92,501 and the stock's 52-week low/high is $1.33500003/$6.30000019.

chart

WeedMD, Inc. (WDDMF)

CannabisMarketCap, Pot Stock News, Micro Small Cap, Financial Insiders, Marijuana Stock Review, Daily Marijuana Observer, Stock Day Media, OTC Markets, Stockwatch, Profit Confidential, The Cannabis Investor, Investor Ideas, New Cannabis Ventures, Financial Buzz, Micro Small Cap, Midas Letter, and Morningstar reported earlier on WeedMD, Inc. (WDDMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, WeedMD, Inc. is a federally-licensed producer and distributor of medical-grade cannabis. It is the publicly-traded parent company of WeedMD Rx, Inc., a federally-licensed producer and distributor of cannabis products for the medical and adult-use markets. WeedMD has a multi-channeled distribution strategy. This includes selling directly to medical patients, strategic relationships across the seniors’ market, and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies. WeedMD is headquartered in Aylmer, Ontario.

The Company owns and operates two facilities. One is a 26,000 sq. ft. facility in Aylmer, Ontario. The other is a 158-acre state-of-the-art greenhouse and outdoor facility in Strathroy, Ontario. Presently, WeedMD has 136,000 square feet of licensed indoor and greenhouse production space across its facilities.

The expectation is that WeedMD will have a total footprint of more than 550,000 square feet of indoor and greenhouse production space online this year. Furthermore, 27 acres of outdoor cultivation has been approved for cultivation. First harvest is expected this autumn. At present, the Aylmer facility produces premium indoor flower.

WeedMD has launched Color™ Cannabis. Color Cannabis was developed specifically for a diverse adult-use market. Color Cannabis products include an assortment of strains, in many formats, developed with premier quality cannabis. Color Cannabis is a first-class brand exclusively available to distributors and select retailers across Canada.

Along with premium dried flower, Color Cannabis will launch new product formats in the coming months. These include pre-rolls, oils, and gel capsules with further consumption formats in development. Color will offer up to 10 unique strains from WeedMD’s proprietary genetics collection. This collection includes several signature strains - Pedro’s Sweet Sativa, Ghost Train Haze, White Shark, ACDC, Ultra Sour and Mango Haze.

WeedMD has also launched CX Industries, Inc., a wholly-owned subsidiary. CX Industries will specialize in extraction, toll processing and third-party product formulation from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have the capacity to process more than 200,000 kgs of biomass at its peak production in 2020.

This past August, WeedMD announced it secured a Health Canada licence amendment approval to expand production into 10 additional 10,000 square foot cultivation rooms and 10 new processing rooms at its state-of-the-art hybrid greenhouse in Strathroy, Ontario. Licensing of the 20 additional rooms and ancillary space more than doubles the Company’s licensed greenhouse production space in Strathroy.

Yesterday, Strainprint® Technologies Ltd., the leader in cannabis data and analytics, welcomed WeedMD to its growing portfolio of cannabis-based subscribers. Strainprint Analytics is built on top of the world's largest real-time observational study of medical cannabis patients, with over 1.4 million anonymized, patient reported outcomes and greater than 70 million data points on strain efficacy.

Mr. Brett Moon, Senior Vice President of Sales and Marketing, WeedMD, said, "Our goal in working with Strainprint is to continue to drive transparency and data-driven efficacy in the cannabis industry. Leveraging Strainprint's technology, we can ensure that our top-quality cannabis products make it to the market in a secure and reliable manner."

WeedMD, Inc. (WDDMF), closed Friday's trading session at $0.95, off by 3.0612%, on 55,436 volume with 69 trades. The average volume for the last 3 months is 73,346 and the stock's 52-week low/high is $0.728299975/$1.71000003.

chart

ProtoKinetix, Incorporated (PKTX)

Allstocks, Investor Village, ResearchPool, OTC PR Group, Trading View, 4-Traders, Wallet Investor, and Stockwatch reported previously on ProtoKinetix, Incorporated (PKTX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Incorporated provides medical researchers with a platform for enhancing cell survival and health, in vitro and in vivo. A molecular biotechnology company, it has developed and patented a family of hyper stable, potent glycopeptides (AAGP®) that enhance engraftment and protection of transplanted cells, organs, tissues and organs used in regenerative medicine. ProtoKinetix has its corporate office in Marietta, Ohio. The Company lists on the OTC Markets’ OTCQB.

At the core of ProtoKinetix’s technology is its patented anti-aging glycopeptide AAGP™. This small molecule (580 Daltons) displays abilities in resolving challenges facing medical researchers in areas such as regenerative medicine and as a therapy for diseases relating to tissue inflammation and oxidation stress. Because of its stability, small size and molecular makeup, it maintains its function in vivo without triggering the body's immune system. It can also function without toxic side effects common in treatments involving larger and less stable compounds.

ProtoKinetix is building value through the independent research of laboratories, university and private, into applications for its AAGP™ molecule. Pertaining to health solutions, there are two primary categories that AAGP™ applications would be divided into. One is regenerative Medicine issues. This includes harvesting, processing, storage and transplanting cells, tissues and organs. The other is treatments for chronic inflammatory conditions and diseases caused by stress factors. This includes UV radiation, oxidation, and cryopreservation and hydrogen cyanide.

Due to the results achieved over the last four years of testing, the University of Alberta has commenced Phase 1 human clinical trials. Additional studies will be expanded to include whole organ transplantation and all therapies that are being developed globally to date; diabetes, retinal degeneration, cardiac repair and manifold other degenerative conditions. In addition, ProtoKinetix is studying the potential impact on several cancer therapies.

Recently, ProtoKinetix announced it reached the mid-point of 3rd stage of testing in retinal cell replacement therapy at the University of British Columbia. The Company stated that functionality testing on experimental models three months post-transplant show encouraging results. The study includes two experimental models over a longer period of time to test whether the AAGP® treated cells continue to develop and mature into retinal cells to potentially restore vision in humans. The Gregory-Evans Retinal Therapeutic Lab at the University of British Columbia is conducting the study.

ProtoKinetix, Incorporated (PKTX), closed Friday's trading session at $0.13, up 30.00%, on 200,407 volume with 27 trades. The average volume for the last 3 months is 95,517 and the stock's 52-week low/high is $0.05/$0.319999992.

chart

Royale Energy,  Inc. (ROYL)

SmallCapVoice, Marketbeat, Wall Street Resources, Investing Futures, WealthMakers, Turn Key Oil, Stock Analyzer, Microcapmillionaires, Jason Bond,   SmarTrend Newsletters, and Oakshire Financial reported earlier on Royale Energy,  Inc. (ROYL), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

Royale Energy, Inc. concentrates on the acquisition, development, and marketing of natural gas and oil. It owns and operates wells in the Sacramento and San Joaquin basins in California and has royalty interests in Alaska.  The Company engages in the production and sale of natural gas;  the acquisition of oil and gas lease interests and proved reserves;  the drilling of exploratory and development wells; and the sale of fractional working interests in wells to undergo drilling. Royale Energy has its corporate office in El Cajon, California. 

Royale Energy has properties encompassing more than 20,000 acres in California and nine 3D seismic surveys in the Sacramento Basin. Currently, the Company operates greater than 60 natural gas wells. It owns interests in 12 natural gas fields in California.

Royale Energy’s North Arbuckle is in Colusa County in the Sacramento Basin. At present, this is the most active area for the Company. It has 10 producing natural gas wells that have produced over 5 billion cubic ft.

Royale has acquired greater than 96,000 acres on the Alaskan North Slope. The acreage spans over 88 miles east and west of the Trans-Alaska pipeline route.

The Company has its Lonestar Field. It includes in excess of 1,000 acres. The Lonestar Field has produced more than five billion cubic ft. of gas from five separate Forbes sandstone reservoirs. The Lonestar Field includes the Goddard 7-1 Well; the Goddard #2 and Goddard #3 (offset wells to the Goddard 7-1); and the Magnum Well.

Additionally,  Royale’s Victor Ranch Field is in Tehama County, in the Northern Sacramento Basin. This field has been producing natural gas for the Company since it drilled its first well there in 1993.

Royale Energy has an agreement with a major independent exploration and development company to expand its joint development agreement in the Sacramento Basin of Northern California. The expanded arrangement covers about 1,900 acres in the Rio Vista Gas Field. Royale will target the Capay and Martinez sands.

Royale Energy and Matrix Oil Management Corporation jointly announced earlier in 2018 the closing and completion of the merger between Royale and Matrix. The merger transaction was approved by the Matrix and Royale Energy shareholders on November 16, 2017. It closed after the companies received the consent of Matrix’s lender, Arena Limited SPV, LLC.

Royale Energy and CIC Partners have created a new Joint Venture (JV) named RMX Resources. This JV will fund, drill and produce oil at the prolific Sansinena Oil Field. CIC contributed an aggregate of $25,000,000 in cash in exchange for an 80 percent equity interest. Royale Energy received a 20 percent equity interest plus working capital in exchange for contribution of Sansinena and surrounding area assets. CIC is a Dallas-based private equity organization.

Recently, Royale Energy announced the appointment of Board Director Mr. Rod Eson as Chief Executive Officer (CEO) effective (immediately). Before accepting the CEO responsibilities at Royale Energy, Mr. Eson served as the CEO of Foothill Energy LLC, a California-focused company he founded in 2004.

Royale Energy,  Inc. (ROYL), closed Friday's trading session at $0.18, up 24.1379%, on 7,961 volume with 5 trades. The average volume for the last 3 months is 23,035 and the stock's 52-week low/high is $0.114699997/$0.389999985.

chart

DroneGuarder, Inc. (DRNG)

OTC Markets, Barchart, StreetRegister.com, Insider Financial, InvestorsHub, 4-Traders, and Emerging Growth.com reported on DroneGuarder, Inc. (DRNG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

DroneGuarder, Inc.  centers on commercializing a drone enhanced home security system as a turnkey solution. The design of its DroneGuarder Mobile App  is to let users have peace of mind within arms length, whether they are in their home or not. Established in San Francisco in 2017,  DroneGuarder has its head office in London, England.

The Company’s solution is app-based. It includes a drone, infrared camera, and an Android mobile app component. Upon an alarm being triggered, the DroneGuarder™ will immediately take off from a wireless charging pad.

The DroneGuarder™ assists in protecting against intruders. Upon an intruder being detected on the sensor net,  one can have the drone fly to the event location. Once there,  one can use the built-in microphone to issue a harsh warning to scare away intruders. If that fails, the high-quality HD film captured of the intruder can be uploaded to the cloud and forwarded to law enforcement agencies.

A variety of DJI drones is available and compatible with the DroneGuarder system. The design of the drones is to respond to commands from a user’s smart phone, and its native remote. This enables one to give it basic orders from anywhere.

DroneGuarder uses Swellpro as its drone supplier. DroneGuarder’s intention is to work jointly to embed its scanning AI image recognition technology into Swellpro’s SD5 drone platform. This will enable the DG Rescue to autonomously grid search for victims in a search area and alert the rescue crews through GPS location and streaming video where the victims are. DroneGuarder will be jointly developing DG Intruder with Swellpro using all the same technology, however it will be app based.

Recently, DroneGuarder announced the launch of its DG App on Google Play. The Company is enhancing the functionality for login and flight control including autonomously and controlled security sweeps. DroneGuarder secured new funding, which enables the Company to fund DG Rescue and DG Intruder product developments through to commercial release.

DroneGuarder believes that once both of its products are launched it will sell 5,000 to 10,000 drone units in the first year. The Company has its channels to market already in place, using Swellpro’s reseller network. Swellpro in 2017 sold roughly 6,000 drones.

DroneGuarder, Inc. (DRNG), closed Friday's trading session at $0.0006, up 20.00%, on 202,400 volume with 7 trades. The average volume for the last 3 months is 4,298,544 and the stock's 52-week low/high is $0.000399999/$0.014999999.

chart

Sunvalley Solar, Inc. (SSOL)

Wallstreetlivechat, PennyStockPros, The Stock Scout, Penny Stock Rumble, Stockhunter.us, PennyStockClub, OurHotStockPicks, PennyStocks24, Fast Moving Stocks, VIP STOCK ALERTS, and FeedBlitz reported previously on Sunvalley Solar, Inc. (SSOL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Sunvalley Solar, Inc., by way of its subsidiary, Sunvalley Solar Tech, Inc., operates as a solar power technology and system integration company in the State of California. The Company centers on solar systems design and installation, solar technology research and development (R&D), and solar equipment manufacturing and distribution areas. Established in 2007, Sunvalley Solar is headquartered in in Walnut, California.

Sunvalley Solar acquired Rayco Energy, Inc. in 2016. Rayco Energy is an established northern California company. It specializes in providing cost-saving and efficient energy solutions to local communities and business units. This includes LED lighting, Solar Thermal, as well as Solar Electricity.

Rayco Energy combines energy efficiency measures with renewable energy sources. It services the multi-family sector (Apartments, Homeowner Associations (HOA)) and small-sized commercial projects.

Sunvalley Solar’s business development strategy is to develop the Company as the end-to-end solar energy solution provider for solar power equipment dealers, solar power system installers, and solar power energy end users.

The Company provides turnkey solar system solutions. These include designing, building, operating, monitoring, and maintaining solar power systems for owners, builders, and architecture firms. Its R&D team comprises PhDs in Optoelectronics. The team specializes in photovoltaic panel technologies (coating and focusing).

In addition, the Company’s focus is in the area of National Solar Technical Support and a Service Center. Sunvalley Solar serves small private residences and large commercial solar power users.

The Company’s R&D team’s projects include 975 kW commercial solar power systems for distribution warehouses and manufacturing companies. Furthermore, projects include 1 MW commercial solar power systems for agriculture farms and cold storage facilities.

Its R&D is presently focusing on developing new coating technology to increase the efficiency of PV panels; developing new focusing technology to reduce the size of silicon cells and reduce the silicon cost per watt; developing solar PV application technology to decrease system level cost; and developing new solar parts – Micro-inverters.

Sunvalley Solar has its patented technology – Networked Solar Panels and Related Methods. It has patented the technology "Networked Solar Panels and Related Methods" (USPTO 12/198,076). This technology enables the solar power system operator to monitor the grid status, and manage and control the output from each panel, each subsystem, and the system as a whole.

Sunvalley Solar, Inc. (SSOL), closed Friday's trading session at $0.027, up 56.9767%, on 2,002 volume with 3 trades. The average volume for the last 3 months is 1,701 and the stock's 52-week low/high is $0.0172/$0.052499998.

chart

Citius Pharmaceuticals, Inc. (CTXR)

MicroCapDaily, Stock Commander, Penny Stock Prodigy, DSR News, PHUB News, Damn Good Penny Picks, Penny Picks, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, OTCMagic, Penny Stock Newsletter, and PREPUMP STOCKS reported previously on Citius Pharmaceuticals, Inc. (CTXR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products. The Company’s concentration is on anti-infectives, cancer care, and innovative prescription products utilizing unique, patented, or proprietary formulations of earlier approved active pharmaceutical ingredients. Citius Pharmaceuticals is headquartered in Cranford, New Jersey.

The Company is now advancing two proprietary product candidates: the Mino-Lok™ product and a hydrocortisone-lidocaine formulation. The Mino-Lok™ product is advancing to Phase 3 clinical studies. The Mino-Lok™ product is an antibiotic lock solution. It is used to treat patients with catheter-related bloodstream infections (CRBSIs). Mino-Lok™ is under investigation and not approved for commercial use.

Citius Pharmaceuticals is developing a proprietary topical formulation of hydrocortisone (3%) and lidocaine (5%) to provide anti-inflammatory and anesthetic relief to persons suffering from Grade I and II hemorrhoids. The Company has achieved positive results from a Phase 2a study for hydrocortisone-lidocaine formulation for Grade I and II hemorrhoids.

Citius Pharmaceuticals has commenced the pivotal Phase 3 clinical trial Mino-Lok™. This is the above-mentioned antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs). Mino-Lok™ is undergoing development as an adjunctive therapy for the treatment of catheter-related or central line associated bloodstream infection (CRBSI/CLABSI). Mino-Lok™ together with suitable systemic antibiotic(s), is used to preserve central venous access and to avoid the complications and morbidities associated with catheter removal and reinsertion.

The Company has obtained top line data from a survey of 31 physicians clearly showing a need for catheter salvage in patients with indwelling central venous lines, especially when the catheter is a tunneled or an implanted port. Nineteen Infectious Disease experts and 12 Intensivists surveyed all agreed that salvage would be preferable to catheter exchange, fearing that catheter misplacements, blood clots, or vessel punctures can potentially occur during reinsertion. Most were also concerned that viable venous access may not be available. The survey was conducted by a third party in January of this year.

Recently, Citius Pharmaceuticals announced that it concluded negotiations to add South America to its global license for Mino-Lok™. South America was the only territory that was not included in the original sub-license between Novel Anti-Infective Technologies, LLC, an affiliate of MD Anderson Cancer Center (MDACC), and Leonard-Meron Biosciences, Inc. (LMB), a wholly-owned subsidiary of Citius Pharmaceuticals.

Citius Pharmaceuticals, Inc. (CTXR), closed Friday's trading session at $0.6101, up 26.8399%, on 225,295 volume with 463 trades. The average volume for the last 3 months is 149,220 and the stock's 52-week low/high is $0.423999994/$1.78999996.

chart

mCig, Inc. (MCIG)

Shiznit Stocks, Stockgoodies, CFN Media Group, The Street, GrowthPennyStocks, Penny Stock General, MadMoneyPicks, MassiveStockProfits, Wall Street Equities Research, Promotion Stock Secrets, TopPennyStockMovers, Stock Shock and Awe, PennyPro, Fast Money Alerts, Cannabis Financial Network News, and SmallCapVoice reported previously on mCig, Inc. (MCIG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

mCig, Inc. is a diversified business serving the legal cannabis, hemp, and CBD markets by way of its lifestyle brands. The Company is a distributor of innovative cannabis related products. mCig has transitioned from a vaporizer manufacturer to an industry leading, large scale, full-service cannabis cultivation construction enterprise. Its Scalable Solutions division presently operates in the fast-expanding Nevada market. The Company’s devotion is to be the foremost distributor of technology, products, and services to the industry. mCig has its corporate office in Henderson, Nevada.

mCig owns the Rollie and Vapolution brands. The Company has its Grow Contractors division that provides services to growers of every level in the developing cannabis industry. This division provides turnkey, durable, completely modular, ISO clean, high-yielding cultivation rooms. This permits growers to create a first-rate growing environment all year.

Regarding Commercial Scale, Grow Contractors utilizes Structurally Insulated Panels to create a hermetically sealed, mold/pest free, and sterile environment. Its panels provide high R-Value thermal resistance, significantly lessening a customer’s energy consumption.

Concerning Grow Greenhouse, Grow Contractors’ Greenhouse Hybrids integrate the efficiency of structurally insulated panels with natural sunlight. It provides flexible multi-tier growing layouts, rollup security/blackout panels, and environmental control.

Furthermore, mCig has partnered with industry leaders and designers to provide a drop and grow solution for the home grower. The Home Grow Rooms are professionally designed, climate controlled rooms. They are suited for beginners and experts.

mCig also offers Consulting Services. This is to help clients navigate state, county, and city regulations for compliancy. Its Consulting Services provide the expertise for this. Additionally, mCig has entered the technology space to satisfy its developing role in technology and in keeping its increasing following informed. mCig also focuses on providing distribution, media and events, and business services within the cannabis industry.

At the beginning of August, mCig announced the extension of its offerings to include merchant processing. The Company has created a new entity, partnering with a merchant provider with more than 10 years of experience, allowing mCig to provide a wide-ranging, seamless, and secure payment solution via a trusted source. After rigorous testing, mCig can provide merchant processing exclusively to cannabis businesses and dispensaries. Its merchant service provides a simple, direct, United States-based solution that can accept credit cards online and at participating dispensaries.

Recently, mCig announced a partnership between its Job Search Portal (420JobSearch.com) and ZipRecruiter.com. 420jobsearch.com recently entered into an agreement with ziprecruiter.com to allow both companies to widen the scope of jobs available to job seekers. mCig's 420JobSearch is considered one of the largest job and recruitment sites in the cannabis industry. It has leading job boards for employers, job seekers, as well as recruiters.

mCig, Inc. (MCIG), closed Friday's trading session at $0.040572, up 21.1104%, on 3,593,352 volume with 237 trades. The average volume for the last 3 months is 641,487 and the stock's 52-week low/high is $0.025399999/$0.299899995.

chart

Omnitek Engineering Corp. (OMTK)

OTCPicks, Marketbeat.com, FeedBlitz, and Penny Stock Rumble reported earlier on Omnitek Engineering Corp. (OMTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Omnitek Engineering Corp. develops and sells proprietary diesel-to-natural gas conversion systems and complementary products. This includes new natural gas engines that utilize the Company’s technology. These provide its international customers with unique alternative energy and emissions control solutions that are sustainable and affordable. Omnitek Engineering has its head office in Vista, California.

The Company’s conversion technology provides fleets with a 100 percent dedicated natural gas engine at a fraction of the cost of a new natural gas engine. The strategic alliance provides an assembly-line remanufacturing process providing the benefits of capacity, consistency, as well as quality. Omnitek Engineering’s commitment is to be at the frontier of technology. In addition, its commitment is to develop pioneering solutions that redefine the future of low emissions, energy independence, and transportation.

Omnitek’s products include New Natural Gas Engines, Engine Specific Diesel-to-Natural Gas (DNG) Engine Conversion Kits, and products for Diesel-to-Natural Gas Engine Conversions, Engine Management System (EMS) and Components, EFI for V-Twin Motorcycles and Small Engines, and Hydrogen Internal Combustion Engines. The DNG system has established Omnitek Engineering as a leader in the industry.

The Company has established a strategic alliance with LKQ Corp. to produce "drop-in" natural gas engines at Omnitek Engineering’s facility in Monterrey, Mexico, first for the extensively-used Mercedes OM904 and OM906 engines. LKQ is a top provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Omnitek Engineering announced in July of 2016 that it received global certification for its patented fuel rail technology. This is founded on tests conducted by an independent agency and standards sanctioned by the United Nations Economic Commission for Europe, specifically UN ECE R110.

Omnitek Engineering will participate in a $1.5 million grant study with its partner Olson-Ecologic Testing Laboratories (Fullerton, California). The study is to demonstrate its clean natural gas engine technology for off-road heavy duty construction vehicle applications in the greater Los Angeles, California area.

Omnitek will develop an 18-liter Caterpillar natural gas engine capable of operating on CNG, LNG, or low-carbon intensive renewable biogas (R-CNG) through using its patented diesel-to-natural gas engine conversion technology. Olson-Ecologic Engine Testing Laboratories will serve as project manager. Olson-Ecologic will be responsible for rigorous testing at its facility before demonstrations under real-life conditions.

Recently, Omnitek Engineering reported results for its Q2 and six months ended June 30, 2017. The results reflect a significantly reduced Net Loss for both periods, an improved cash position, as well as the start of an earlier announced grant program to develop an 18-liter off-road natural gas engine.

Omnitek Engineering Corp. (OMTK), closed Friday's trading session at $0.10, up 17.6471%, on 17,499 volume with 6 trades. The average volume for the last 3 months is 24,001 and the stock's 52-week low/high is $0.039999999/$0.219899997.

chart

The QualityStocks Company Corner

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in a publication from CBDWire, examining how, ever since cannabidiol (CBD) was legalized in Alabama, CBD shops and social events have been popping up like weeds all over the state. Most of them are geared at destigmatizing CBD and pushing their products. On Monday, HempWorx hosted its social event in Jefferson County, and people were invited to come learn all about CBD (and purchase a product or two).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $3.16, up 16.1765%, on 5,920,100 volume with 13,090 trades. The average volume for the last 3 months is 1,197,861 and the stock's 52-week low/high is $2.71000003/$8.43999958.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, has developed a consumer-managed data marketplace where people can own and earn from their data. As new privacy laws come into play in California, Los Angeles-based SRAX is already ahead of the competition.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $2.12, up 4.9505%, on 100,638 volume with 527 trades. The average volume for the last 3 months is 94,843 and the stock's 52-week low/high is $1.54999995/$5.8499999.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a company dedicated to growing the world’s best cannabis and becoming a leader in the global industry, is creating inroads into Europe’s cannabis industry through its various subsidiaries. The company is taking an aggressive approach to secure its position in Europe’s rapidly increasing cannabis market, a market worth an estimated $318 million in 2018, which is expected to grow more than 400 percent through 2023 (http://cnw.fm/xvjI2).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.693, up 0.434783%, on 577,435 volume with 560 trades. The average volume for the last 3 months is 481,816 and the stock's 52-week low/high is $0.670000016/$1.7888.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

Gas, liquids and biomass extractor and refiner HTC Extraction Systems (TSX.V: HTC), together with its subsidiaries, has developed a proprietary. ethanol-based distillation system called the Delta Purification System(R), which works with the company’s DeltaSolv(TM) technologies. To view the full article, visit http://cnw.fm/9Ibrl.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Friday's trading session at $0.47, up 17.50%, on 188,200 volume with 19 trades. The average volume for the last 3 months is 108,404 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

A science-based biotech company, Earth Science Tech Inc. (OTCQB: ETST)operates in the hemp-derived cannabinoids, nutraceuticals, pharmaceuticals, medical-devices, and research and development (R&D) fields. The company focuses on researching and developing unique hemp extracts and making those extracts accessible globally. The company offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Friday's trading session at $0.3201, up 1.619%, on 39,100 volume with 15 trades. The average volume for the last 3 months is 44,676 and the stock's 52-week low/high is $0.300999999/$1.79999995.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF), a public cannabis company developing brands that focus on plant-based wellness and health products, is concentrating its efforts on being a worldwide supplier of CBD products for wellness and health. To view the full article, visit http://cnw.fm/5LVrm.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed Friday's trading session at $0.2521, up 0.678914%, on 6,919 volume with 15 trades. The average volume for the last 3 months is 11,319 and the stock's 52-week low/high is $0.221100002/$0.865499973.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated, surface oil-sands, clean-recovery mining oil company with proprietary technology, recently announced the initiation of commissioning processes and ‎sequences for its Asphalt Ridge facility in Utah (http://nnw.fm/t5Jom). To view the full article, visit http://nnw.fm/5WcAW.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Friday's trading session at $0.1936, up 7.5556%, on 357,369 volume with 43 trades. The average volume for the last 3 months is 236,764 and the stock's 52-week low/high is $0.112099997/$0.847999989.

Recent News

chart

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company specializing in the recreational adult-product market, recently reported second-quarter 2019 financial results, including a revenue milestone of $5.9 million (http://cnw.fm/8Ueu8). To view the full press release, visit http://cnw.fm/gn6dS. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. A new study on the impacts of marijuana, which was funded by the U.S. Department of Justice, showed that marijuana programs do not affect neighboring or non-legal states negatively.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Friday's trading session at $0.031, up 9.5406%, on 212,795 volume with 31 trades. The average volume for the last 3 months is 280,113 and the stock's 52-week low/high is $0.0215/$0.634559988.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Neutra Corp. (OTCQB: NTRR) has terminated a proposed reverse stock split. Instead, the Company will focus on several potential acquisitions now in discussions designed to make Neutra a more vertically integrated company capable of competing in the skyrocketing CBD (cannabidiol) market. Also today, the company was highlighted in a publication from CBDWire, examining how ever since cannabidiol (CBD) was legalized in Alabama, CBD shops and social events have been popping up like weeds all over the state. Most of them are geared at destigmatizing CBD and pushing their products.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Friday's trading session at $0.0019, up 153.3333%, on 237,276,750 volume with 724 trades. The average volume for the last 3 months is 24,108,121 and the stock's 52-week low/high is $0.0006/$0.0898.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. A new study on the impacts of marijuana, which was funded by the U.S. Department of Justice, showed that marijuana programs do not affect neighboring or non-legal states negatively. The new study authors, while conducting their state-level analysis, were looking to answer three questions; first, the impact of legalization on law enforcement resources in legal states.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $2.24, off by 7.6174%, on 53,882 volume with 153 trades. The average volume for the last 3 months is 36,747 and the stock's 52-week low/high is $2.17000007/$6.00810003.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) was featured today in a publication from HempWireNews, examining how according to the Augusta Free Press, two researchers, Shane Ross and Hussein Foroutan, from Virginia Tech and University of Tennessee, Knoxville, who are studying the transport of pollen from genetically modified hemp and switchgrass were awarded a $500,000 grant by the U.S. Department of Agriculture. To learn how the plants’ pollen travels, the team will apply mathematical models and drones.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Friday's trading session at $2.04, off by 5.5556%, on 14,634 volume with 31 trades. The average volume for the last 3 months is 19,396 and the stock's 52-week low/high is $0.100100003/$2.31999993.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI) is a developer of highly adaptable assessment methods for cancer patients to help guide personalized treatments. To view the full article, visit http://nnw.fm/iW9k5.

Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Predictive Oncology (POAI), closed Friday's trading session at $0.43, off by 4.4869%, on 35,098 volume with 70 trades. The average volume for the last 3 months is 61,627 and the stock's 52-week low/high is $0.360000014/$0.850000023.

Recent News

chart

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

New York City-based intellectual property (IP) asset management company Quest Patent Research Corp. (OTCQB: QPRC) is fully committed to supporting individual inventors and small companies protect and monetize their innovations by partnering with them in prosecuting patents, identifying monetization opportunities and protecting them from patent infringement or IP theft.

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Friday's trading session at $0.0136, off by 20.00%, on 281,574 volume with 18 trades. The average volume for the last 3 months is 301,028 and the stock's 52-week low/high is $0.001799999/$0.039999999.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING)was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth CEO and executive interviews that offer insights into operations and future outlooks. To view the full press release, visit http://cnw.fm/1mRsP.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.01094, off by 0.40965%, on 2,388,341 volume with 84 trades. The average volume for the last 3 months is 2,955,828 and the stock's 52-week low/high is $0.009999999/$0.035999998.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.